Clinical Trial Update: A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core) [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating the safety and immunogenicity of two experimental HIV vaccines, eOD-GT8 60mer mRNA Vaccine (mRNA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core)
• eOD-GT8 60mer mRNA Vaccine (mRNA-1644)

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: Hiv | Phase 1 | Status: ACTIVE_NOT_RECRUITING